361 related articles for article (PubMed ID: 32131831)
1. Engineering probiotics as living diagnostics and therapeutics for improving human health.
Zhou Z; Chen X; Sheng H; Shen X; Sun X; Yan Y; Wang J; Yuan Q
Microb Cell Fact; 2020 Mar; 19(1):56. PubMed ID: 32131831
[TBL] [Abstract][Full Text] [Related]
2. Engineered probiotics as live biotherapeutics for diagnosis and treatment of human diseases.
Meng J; Liu S; Wu X
Crit Rev Microbiol; 2024 May; 50(3):300-314. PubMed ID: 36946080
[TBL] [Abstract][Full Text] [Related]
3. Biotherapy Using Probiotics as Therapeutic Agents to Restore the Gut Microbiota to Relieve Gastrointestinal Tract Inflammation, IBD, IBS and Prevent Induction of Cancer.
Dahiya D; Nigam PS
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982816
[TBL] [Abstract][Full Text] [Related]
4. Targeting friend and foe: Emerging therapeutics in the age of gut microbiome and disease.
Cho JA; Chinnapen DJF
J Microbiol; 2018 Mar; 56(3):183-188. PubMed ID: 29492875
[TBL] [Abstract][Full Text] [Related]
5. Role of Probiotics in Human Gut Microbiome-Associated Diseases.
Kim SK; Guevarra RB; Kim YT; Kwon J; Kim H; Cho JH; Kim HB; Lee JH
J Microbiol Biotechnol; 2019 Sep; 29(9):1335-1340. PubMed ID: 31434172
[TBL] [Abstract][Full Text] [Related]
6. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
[TBL] [Abstract][Full Text] [Related]
7. Living Therapeutics: The Next Frontier of Precision Medicine.
Kelly VW; Liang BK; Sirk SJ
ACS Synth Biol; 2020 Dec; 9(12):3184-3201. PubMed ID: 33205966
[TBL] [Abstract][Full Text] [Related]
8. Gut Microbiota in Celiac Disease: Is There Any Role for Probiotics?
Pecora F; Persico F; Gismondi P; Fornaroli F; Iuliano S; de'Angelis GL; Esposito S
Front Immunol; 2020; 11():957. PubMed ID: 32499787
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in gut Microbiota mediated therapeutic targets in inflammatory bowel diseases: Emerging modalities for future pharmacological implications.
Shamoon M; Martin NM; O'Brien CL
Pharmacol Res; 2019 Oct; 148():104344. PubMed ID: 31400403
[TBL] [Abstract][Full Text] [Related]
10. Metabolic engineering of human gut microbiome: Recent developments and future perspectives.
Li P; Roos S; Luo H; Ji B; Nielsen J
Metab Eng; 2023 Sep; 79():1-13. PubMed ID: 37364774
[TBL] [Abstract][Full Text] [Related]
11. Advanced probiotics: bioengineering and their therapeutic application.
Parvin T; Sadras SR
Mol Biol Rep; 2024 Feb; 51(1):361. PubMed ID: 38403783
[TBL] [Abstract][Full Text] [Related]
12. Next generation probiotics in disease amelioration.
Chang CJ; Lin TL; Tsai YL; Wu TR; Lai WF; Lu CC; Lai HC
J Food Drug Anal; 2019 Jul; 27(3):615-622. PubMed ID: 31324278
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiota and inflammatory bowel disease: so far so gut!
Holleran G; Lopetuso LR; Ianiro G; Pecere S; Pizzoferrato M; Petito V; Graziani C; McNAMARA D; Gasbarrini A; Scaldaferri F
Minerva Gastroenterol Dietol; 2017 Dec; 63(4):373-384. PubMed ID: 28293937
[TBL] [Abstract][Full Text] [Related]
14. The potential impact of gut microbiota on your health:Current status and future challenges.
Sirisinha S
Asian Pac J Allergy Immunol; 2016 Dec; 34(4):249-264. PubMed ID: 28042926
[TBL] [Abstract][Full Text] [Related]
15. Regulation of gut microbiota-bile acids axis by probiotics in inflammatory bowel disease.
Li L; Liu T; Gu Y; Wang X; Xie R; Sun Y; Wang B; Cao H
Front Immunol; 2022; 13():974305. PubMed ID: 36211363
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic implications of probiotics in microbiota dysbiosis: A special reference to the liver and oral cancers.
Singh D; Khan MA; Siddique HR
Life Sci; 2021 Nov; 285():120008. PubMed ID: 34606851
[TBL] [Abstract][Full Text] [Related]
17. Intestinal Engineered Probiotics as Living Therapeutics: Chassis Selection, Colonization Enhancement, Gene Circuit Design, and Biocontainment.
Huang Y; Lin X; Yu S; Chen R; Chen W
ACS Synth Biol; 2022 Oct; 11(10):3134-3153. PubMed ID: 36094344
[TBL] [Abstract][Full Text] [Related]
18. Potential Impacts of Prebiotics and Probiotics on Cancer Prevention.
Samanta S
Anticancer Agents Med Chem; 2022; 22(4):605-628. PubMed ID: 33305713
[TBL] [Abstract][Full Text] [Related]
19. Synthetic Biology Approaches to Engineer Probiotics and Members of the Human Microbiota for Biomedical Applications.
Bober JR; Beisel CL; Nair NU
Annu Rev Biomed Eng; 2018 Jun; 20():277-300. PubMed ID: 29528686
[TBL] [Abstract][Full Text] [Related]
20. Engineering Diagnostic and Therapeutic Gut Bacteria.
Landry BP; Tabor JJ
Microbiol Spectr; 2017 Oct; 5(5):. PubMed ID: 29052539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
